台股 » 個股 » 健亞 » 籌碼相關 » 券商分點績效

健亞

(4130)
可現股當沖
  • 股價
    23.90
  • 漲跌
    --
  • 漲幅
    0.00%
  • 成交量
    107
  • 產業
    上櫃 生技醫療類股
  • 150人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
健亞 (4130)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2024/04/16     後一日»

券商獲利排行 - 2024/04/16

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  1.13%11.80.711.1-4034324.22424.223.9
  1.65%7.207.2-1801824.3024.323.9
  0.49%4.104.1-350352402423.9
  1.39%4.104.1-1201224.2024.223.9
  0.53%3.303.3-260262402423.9
  0.87%3.203.2-1501524.1024.123.9
  1.85%2.702.7-60624.4024.423.9
  1.29%2.502.5-80824.2024.223.9
  1.85%2.302.3-50524.4024.423.9
  1.81%2.202.2-50524.3024.323.9
  0.66%1.61.600101024.12424.123.9
  0.48%1.11.5-0.4310724.12424.323.9
  0.95%1.10.80.304524.12424.223.9
  0.42%101-100102402423.9
  1.85%0.900.9-20224.4024.423.9
  0.83%0.800.8-40424.1024.123.9
  1.65%0.800.8-20224.3024.323.9
  1.44%0.700.7-20224.3024.323.9
  0.24%0.600.6-110112402423.9
  0.42%0.600.6-6062402423.9
  0.62%0.600.6-40424.1024.123.9
  0.21%0.500.5-100102402423.9
  1.85%0.500.5-10124.4024.423.9
  1.24%0.300.3-10124.2024.223.9
  1.04%0.300.3-10124.2024.223.9
  0.12%0.200.2-70723.9023.923.9
  0.62%0.200.2-10124.1024.123.9
  0.42%0.100.1-1012402423.9
  0.21%0.100.1-2022402423.9
  0.42%0.100.1-1012402423.9
  0.42%0.100.1-1012402423.9
  0.42%0.100.1-1012402423.9
  0.42%0.100.1-1012402423.9
  0.03%0.100.1-80823.9023.923.9
  0.07%0.100.1-30323.9023.923.9
  0.21%0.100.1-1012402423.9
  0.10%0.100.1-11224242423.9
  0.21%0.100.1-1012402423.9
  0.21%0.100.1-1012402423.9
  0.21%0.100.1-1012402423.9
  0.21%0.100.1-1012402423.9
  0.21%0.100.1-1012402423.9
  0.21%0.10.1001124242423.9
  0.00%000-40423.9023.923.9
  0.00%000-20223.9023.923.9
  0.00%000-10123.9023.923.9
  0.00%000-10123.9023.923.9
   00000024.5024.523.9
   00000024.324.3023.9
   00000024.124.1023.9

券商虧損排行 - 2024/04/16

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -1.26%-3.70-3.71212024.224.2023.9
  -1.85%-3.20-3.277024.424.4023.9
  -1.28%-2.80-2.899024.224.2023.9
  -1.85%-2.70-2.766024.424.4023.9
  -1.75%-2.60-2.666024.324.3023.9
  -1.44%-2.50-2.577024.324.3023.9
  -1.65%-20-255024.324.3023.9
  -1.10%-1.60-1.666024.224.2023.9
  -1.65%-1.60-1.644024.324.3023.9
  -1.24%-1.50-1.555024.224.2023.9
  -0.97%-1.40-1.466024.124.1023.9
  -1.44%-1.40-1.444024.324.3023.9
  -1.65%-1.20-1.233024.324.3023.9
  -1.65%-1.20-1.233024.324.3023.9
  -0.33%-1.1-0.1-1914524242423.9
  -1.14%-1.1-1.1004424.124.22423.9
  -0.42%-10-1101002424023.9
  -0.42%-10-1101002424023.9
  -1.04%-10-144024.224.2023.9
  -1.38%-10-133024.224.2023.9
  -1.31%-10-133024.224.2023.9
  -1.10%-0.8-0.5-0.313224.124.22423.9
  -0.55%-0.8-0.90.2-24624.124.22423.9
  -0.62%-0.80-0.855024.124.1023.9
  -0.78%-0.80-0.844024.124.1023.9
  -0.97%-0.70-0.733024.124.1023.9
  -1.44%-0.70-0.722024.324.3023.9
  -0.54%-0.70-0.75502424023.9
  -1.24%-0.60-0.622024.224.2023.9
  -2.25%-0.60-0.611024.524.5023.9
  -0.42%-0.50-0.55502424023.9
  -1.04%-0.50-0.522024.224.2023.9
  -1.04%-0.50-0.522024.224.2023.9
  -0.62%-0.50-0.533024.124.1023.9
  -0.93%-0.50-0.522024.124.1023.9
  -0.93%-0.50-0.522024.124.1023.9
  -1.85%-0.50-0.511024.424.4023.9
  -1.85%-0.50-0.511024.424.4023.9
  -0.83%-0.40-0.422024.124.1023.9
  -1.65%-0.40-0.411024.324.3023.9
  -1.65%-0.40-0.411024.324.3023.9
  -1.65%-0.40-0.411024.324.3023.9
  -0.40%-0.40-0.424224.124.124.123.9
  -0.21%-0.40-0.47702424023.9
  -0.73%-0.40-0.422024.124.1023.9
  -0.48%-0.40.3-0.623124.324.224.523.9
  -1.44%-0.40-0.411024.324.3023.9
  -0.63%-0.30-0.31202424.123.923.9
  -0.42%-0.30-0.33302424023.9
  -1.24%-0.30-0.311024.224.2023.9
新藥研發 浩鼎子公司抗癌新藥申請一期臨床 健亞明年完成試驗Anue鉅亨-2022/09/12
健亞 相關文章